Ono’s Stock Price Decline on Merck’s KN-042 Success
Merck & Co. (NYSE: MRK), on April 09, 2018, announced Keytruda’s (pembrolizumab) success in improving overall survival (OS) as 1L treatment in...
202 Views
Cyberdyne (7779) - Is This the Death-Knell for Short Sell Reports on Japanese Stocks?
Shares in Cyberdyne (7779 JP) have surged following the news that it has gained approval in the US for its "Medical HAL" exoskeleton suit to be...
562 Views
ONO Pharma 4528JP - 20-30% Upside
PREFERRED CASERemain bullish above 2400 to 3130 even 3535.Congestion breakout and pullback at 2400. RSI 21 confirms the breakout. Should you have...
242 Views
Sosei & Kyowa Hakko Kirin: Positive News on GPCR Drugs
Kyowa Hakko Kirin's (4151 JP) announcement that “moga” – mogamulizumab (KW-0761) – has met its primary endpoint (PFS) in Phase III trials for...
405 Views
Ono Pharmaceutical: Time to Accumulate
New entry into our Asia Pacific Model Portfolio at 4.54% weight: We added Ono Pharmaceutical Co Ltd (4528 JP) to our Asia Pacific Model Portfolio...
474 Views